國內 Laidlaw 给予 Nasus Pharma 买入评级，过敏性休克药物成关键因素 Editorial 30 9 月, 2025 Laidlaw & Company 最近... Read MoreRead more about Laidlaw 给予 Nasus Pharma 买入评级，过敏性休克药物成关键因素
國內 BMO Capital上调Alnylam Pharmaceuticals目标价，Zilebesiran前景受看好 Editorial 8 9 月, 2025 近日，BMO Capital Marke... Read MoreRead more about BMO Capital上调Alnylam Pharmaceuticals目标价，Zilebesiran前景受看好
